top
Please input keywords
Order
*Country
United States
China
France
Germany
Netherlands
United Kingdom
Japan
South Korea
Israel
Australia
Hong Kong, China
New Zealand
Russia
Singapore
Taiwan, China
India
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Ascension Island
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Ceuta & Melilla
Chad
Chile
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Diego Garcia
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
Indonesia
Iran
Iraq
Ireland
Isle of Man
Italy
Jamaica
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
New Caledonia
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia & South Sandwich Islands
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Helena
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Svalbard & Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Outlying Islands
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Nations
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hIL36R/hIL1RACP mice
Strain Name C57BL/6-Il1rl2tm1(IL1RL2)BcgenIl1raptm1(hIL1RAP)Bcgen/Bcgen  Common Name  B-hIL36R/hIL1RACP mice
Background C57BL/6 Catalog number 112383
Related Genes 

IL1RL2, IL-1Rrp2, IL-36R, IL1R-rp2, IL1RRP2, interleukin 1 receptor like 2;

IL1RAP; IL1RAcP; IL1R3; C3orf13

mRNA expression analysis


from clipboard


Strain specific analysis of IL36R gene expression in wild type (WT) mice, B-hIL36R mice and B-hIL36R/hIL1RACP mice by RT-PCR. Human IL36R mRNA was detectable only in lung of homozygous B-hIL36R mice (H/H) and homozygous B-hIL36R/hIL1RACP mice (H/H;H/H) but not in WT mice (+/+). The positive band was confirmed to be correct by sequencing.

Protein expression analysis

from clipboard


Strain specific IL1RACP expression analysis in homozygous B-hIL36R/hIL1RACP mice by flow cytometry. Monocytes, macrophages and neutrophils were collected from wild type (WT) mice (+/+) and homozygous B-hIL36R/hIL1RACP mice (H/H;H/H), and analyzed by flow cytometry with species-specific anti-hIL1RACP antibody. Human IL1RACP was exclusively detectable in homozygous B-hIL36R/hIL1RACP mice (H/H;H/H) but not in WT mice (+/+).


Blood routine test in B-hIL36R/hIL1RACP mice


from clipboard


Complete blood count (CBC). Blood from female C57BL/6 and B-hIL36R/hIL1RACP mice (n=8, 8 week-old) was collected and analyzed for CBC. There was no differences among any measurement between C57BL/6 and B-hIL36R/hIL1RACP mice, indicating that introduction of IL36R and IL1RACP in place of its mouse counterpart do not change blood cell composition and morphology. Values are expressed as mean ± SEM.

Blood biochemistry of B-hIL36R/hIL1RACP mice

from clipboard

Blood biochemistry tests of B-hIL36R/hIL1RACP mice. Serum from the C57BL/6 and B-hIL36R/hIL1RACP mice (n=8, 8 week-old) was collected and analyzed for levels of ALT and AST. There was no differences on either measurement between C57BL/6 and B-hIL36R/hIL1RACP mice, indicating that introduction of IL36R and IL1RACP in place of its mouse counterpart do not change ALT and AST levels or health of liver. Values are expressed as mean ± SEM.




IL36g-induced skin inflammation in B-hIL36R/hIL1RACP mice


from clipboard


Homozygous B-hIL36R/hIL1RACP mice were induced ear skin inflammation with injection of human IL36g cytokine (2ug/25uL per dose) intradermal in ear skin, and pre-treated with IL-36 pathway blocker Spesolimab i.v. (10 mg/kg), and measuring ear skin thickness. The results showed that human IL-36g cytokine induced the ear skin inflammation significantly in B-hIL36R/hIL1RACP mice as the ear skin thickening, and IL-36 pathway blocker Spesolimab could relieve skin inflammation. Values are expressed as mean ± SEM. The data was obtained from a partner.